Head and Neck Cancer

Head and Neck Cancer

SS 31 - H&N 3 - Strategies to Improve Outcomes and Minimize Toxicity in Oropharyngeal Cancer

10/23/2018
4:45 PM - 6:15 PM
Location: Room 214 A/B

Session Type: Scientific
1.50 AMA PRA Category 1 Credits™
1.50 CAMPEP Credits

Presentations:

Hiram Gay, MD, BS

Disclosure:
Employment
Washington University School of Medicine: Associate Professor: Employee

Biography:
Hiram A. Gay, MD is an Associate Professor, Radiation Oncologist in the Department of Radiation Oncology at Washington University School of Medicine, St. Louis, Missouri. He earned a medical degree from University of Puerto Rico in 2000 and completed his residency in radiation oncology at SUNY Upstate Medical University in 2005. Dr. Gay joined the Washington University School of Medicine faculty in 2009 from East Carolina University. The Brody School of Medicine. His clinical practice and academic interests include cancer of the genitourinary area (prostate, urologic, bladder and kidney) cancer and head and neck cancer. He serves as the Medical Director of Radiation Oncology at Siteman Cancer Center-South County, St. Louis, Missouri..

Presentation(s):

Send Email for Hiram Gay

C Jillian Tsai, MD, PhD, MS

Memorial Sloan Kettering Cancer Center

Disclosure:
No relationships to disclose.

Biography:
C. Jillian Tsai, MD, PhD
Radiation Oncologist and Director of Head and Neck Radiation Oncology Research
Memorial Sloan Kettering Cancer Center.

I am a board-certified radiation oncologist and epidemiologist with a clinical emphasis on delivering personalized and effective radiation therapy while minimizing treatment-related side effects. My research focuses on population-based cancer studies, cancer epidemiology, radiation-related toxicities, and clinical trials using novel technology/therapeutics. I have a particular interest in HPV- and EBV-associated malignancies, am developing clinical trials that integrate advanced radiation therapy techniques with other novel therapeutics to improve cancer care outcome as well as quality of life for these patients. I have also studied extensively the normal tissue toxicities in relation to radiation dosimetric factors. Additionally, I am interested in developing novel radiation treatment approaches for patients with metastatic disease.

Presentation(s):

Send Email for C Jillian Tsai


Assets

SS 31 - H&N 3 - Strategies to Improve Outcomes and Minimize Toxicity in Oropharyngeal Cancer



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for SS 31 - H&N 3 - Strategies to Improve Outcomes and Minimize Toxicity in Oropharyngeal Cancer